Newsroom

Promising clinical trial for cancer treatment using gut microbes

Why gut bacteria is the next frontier in medicine R&D

Scientists search far and wide for treatments and cures for the diseases that cause great amounts of human suffering, from cancer to Parkinson’s. But the treatments for these and other debilitating conditions may be far closer to home than many realise.

Validating the mechanism of action of BMC333 consortia through pre-clinical studies in IBD models

Biomica Ltd. has announced the opening of a second site at The Davidoff Cancer Center for its ongoing Phase

Biomica raises $20m. to advance pipeline of microbiome-based therapeutics

Israeli microbiome co Biomica raises $20m

The results demonstrate the efficacy of Biomica’s live bacterial consortia, BMC426 and BMC427, for the treatment of IBS

Biomica raises $20M to advance microbiome-based therapeutics pipeline

$20 Million Funding For AI-Driven Microbiome-Based Therapeutics

The results demonstrate the efficacy of Biomica’s live bacterial consortia, BMC426 and BMC427, for the treatment of IBS

Cancer treatment not working? Gut bacteria could be cure

Biomica Ltd. has announced the opening of a second site at The Davidoff Cancer Center for its ongoing Phase

Positive pre-clinical results for Biomica, Evogene’s subsidiary, in its Immuno-Oncology Program